A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT. DaraEx plus is available from inno-train.
Certificate Directive 98/79/EC, issued May 20th, 2022
Now available: recombinant HLA class I and HLA class II proteins from imusyn.
A recent publication in Transfusion features our new KN antigens, available from inno-train.
EN ISO 13485:2016, issued June 17th, 2020